Proteases and phospholipases activities of Candida albicans isolated from vaginal secretions with different pH;Actividades proteinasa y fosfolipasa de aislamientos de Candida albicans provenientes de secreciones vaginales con distintos valores de pH

Revista Iberoamericana de Micologia

Volumn 25, Issue 1, 2008, Pages 12-16

  Ombrella, Adriana M ^a   Racca, Liliana ^b   Ramos, Laura ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

pH; Phospholipases; Proteinases; Virulence factors; Vulvovaginal candidiasis

Indexed keywords

PHOSPHOLIPASE; PROTEINASE;

ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FUNGAL VIRULENCE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; NONHUMAN; PATHOGENESIS; PH; PROTEIN DEGRADATION; VAGINA CANDIDIASIS; VAGINA SECRETION;

BACTERIA (MICROORGANISMS); BOVINAE; CANDIDA; CANDIDA ALBICANS;

EID: 42049121430     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-1406(08)70004-4     Document Type: Article

References (40)

1. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmer KK. Nonspecific vaginitis; diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
2. Basu S, Guguani HC, Joshi S, Gupta N. Distribution of Candida species in different clinical sources in Delhi, India, and proteinase and phospholipase activity of Candida albicans isolates. Rev Iberoam Micol 2003; 20: 137-140.
3. Belmonte A, Nogueras MG, Ombrella AM, Ruiz Abad I, de los Ángeles Nistal M, Sutich EG, Caffarena GE, Dlugovitzky DG. Estudio microbiológico de vaginitis y vaginosis en mujeres sexualmente activas. Medicina (Buenos Aires) 2002; 62: 103-106.
4. Binolfi A, Biasoli MS, Luque AG, Tosello ME, Magaró HM. High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina. Med Mycol 2005; 43: 431-437.
5. De Bernardis F, Arancia S, Morelli L, Huber B, Sanglard D, Schäfer W, Cassone A. Evidence that members of de secretory aspartyl proteinase gen family, in particular sap2, are virulence factors for Candida vaginitis. J Infect Dis 1999; 179: 301-308.
6. De Bernardis F, Boccanera M, Adriani D, Spreghin E, Santoni D, Cassone A. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 1997; 65: 3399-3405.
7. De Bernardis F, Lorenzini R, Verticchio R, Agantensi L, Cassone A. Isolation acid proteinase secretion and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis. J Clin Microbiol 1989; 27: 2598-2603.
8. De Bernardis F, Molinari A, Boccanera M. Modulation of cell surface associated mannanprotein antigen expression in experimental candidal vaginitis. Infect Immun 1994; 62: 509-519.
9. De Bernardis F, Mondello G, Scaravelli A, Pachi A, Girolomo A, Agatensi L, Cassone A. High aspartyl proteinase production and vaginitis in human immunodeficiency virus- infected women. J Clin Microbiol 1999; 37: 1376-1380.
10. De Bernardis F, Mühlschlegel FA, Cassone A, Fonzi WA. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun 1998; 66: 3317-3325.
11. Echeverría A, Durante AG, Arechavala A, Negroni R. Estudio comparativo de dos medios de cultivo para la detección de la actividad fosfolipasa en cepas de Candida albicans y Cryptococcus neoformans. Rev Iberoam Micol 2002; 19: 95-98.
12. Fidel PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996; 9: 335-348.
13. Ghannoum MA. Potencial rol of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 915-926.
14. Hernández E, Colina M, Villalobos N. Infecciones bacterianas y micóticas del tracto genital inferior, en pacientes del sexo femenino VIH positivas. Kasmera 2003; 31: 104-111.
15. Holst E, Svensson I, Skarin A, Westrom L, Mardh PA. Vaginal colonization with Garderella vaginalis and anaerobic curved rods. Scand J Urol Nephrol 1984; 86 (Suppl): 147-152.
16. Holst E, Wathne B, Hovelius B, Mardh PA. Bacterial vaginosis: microbiological and clinical findings. Am J Med 1983; 74: 14-22.
17. 1) gene. Ferns Microbiol Lett 1998; 167: 163-169.
18. Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1996; 7: 55-69.
19. Hube B. Possible role of secreted aspartyl proteinases in Candida albicans infections. Rev Iberoam Micol 1998; 15: 65-68.
20. Koneman EW, Allen SD, Dowell VR, Janda WM, Sommers HM, Winn WC. Diagnóstico Microbiológico, Buenos Aires, Editorial Médica Panamericana, 1992.
21. Kumar G, Kumar SJ, Menon T. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia 2006; 161: 213-218.
22. Mendling W, Seebacher C. Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics. Mycoses 2003; 46: 365-369.
23. Morrow B, Ramsey H, Soll DR. Regulation of phase-specific genes in the more general switching system of Candida albicans strain 3153A. J Med Vet Micol 1994; 32: 287-294.
24. 1) under various environmental and physiological conditions. Microbiology 2003; 149: 261-267.
25. Naglik J, Albrech A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 2004; 6: 915-926.
26. Naglik JR, Challancombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003; 67: 400-428.
27. Oriel JD, Partridge BM, Denny MJ, Colman JC. Genital yeast infection. Br Med J 1992; 4: 761-764.
28. Ozcan S, Kaynak F, Kalkanci A, Abbasoglu U, Kustimur S. Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents. Mem Inst Oswaldo Cruz 2005; 100: 319-324.
29. Price MF, Wilkinson ID, Gentry LO. Plate method for detention of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7-14.
30. Ray TL, Payne CD. Comparative production and rapid purification of Candida acid proeinase from protein-supplemented cultures. Infect Immun 1990; 58: 508-514.
31. Rodgers CA, Beardall AJ. Recurrent vulvovaginal candidiasis: why does it occur? International J of STD and aids 1999; 10: 435-441.
32. Rodriguez A, Mardh PA, Pina Vaz C, Martinez de Olivera J, Freitas Da Fonseca A. Is the lack of concurrence of bacterial vaginosis and vaginal candidiasis explained by the presence of bacterial amines? Am J Obstet Gynecol 1999; 181: 367-370.
33. Schaller M, Borelli C, Korting HC, Hube B. Hidrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48: 365-377.
34. Sobel JD, Muller G, Buckley HR. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun 1984; 44: 576-580.
35. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988; 544: 547-557.
36. Soll DR. High-frequency switching in Candida albicans and its relations to vaginal candidiasis. Am J Obstet Gynecol. 1988; 158: 997-1001.
37. Tozzini R, Ruiz Abad I, Molteni O, Belmonte A, Nogueras M, Ombrella A. Investigación de la flora autóctona y de transmisión sexual en 100 mujeres sintomáticas y asintomáticas. Obstet Ginecol Latinoam 1998; 56: 185-188.
38. Vidotto V, Pontón J, Aoki S, Quindós G, Mantoan B, Pugliese A, Ito-Kuwa S, Nakamura K. Differences in extracellular enzimatic activity between Candida dubliniensis and Candida albicans isolates. Rev Iberoam Micol 2004; 21: 70-74.
39. Wagner T, Borg M, Zepelin V, Rüchel R. pH-dependent denaturation of extracellular aspartic proteinases from Candida species. J Med Vet Mycol 1995; 33: 275-278.
40. White TC, Agabian N. Candida albicans secreted aspartyl proteinases: Isoenzyme pattern is determined by cell type levels are determined by environmental factors. J Bacteriol 1995; 177: 5215-5221.